Current location：home page
> Enzymotec
Enzymotec
Neptune fails to reach patent agreement with Enzymotec
Neptune and Acasti, a Neptune subsidiary, have announced that they have been unable to conclude a fi…
Neptune vs. Enzymotec: the war of words continues
Neptune has announced that the United States Patent and Trademark Office (“USPTO”) recently issued a…
Chinese demand for infant foods driving innovation
China is setting the regional benchmark for innovation in premium infant foods, according to Enzymot…
Enzymotec’s infant nutrition ingredients yield positive results in clinical trials
Enzymotec has announced that clinical trials for its lipid-based ingredient line for infant nutritio…
Enzymotec says infant nutrition trials were successful
Biotech company Enzymotec has reported that clinical trials for its lipid-based ingredient line for…
Trial demonstrates beta-palmitate benefits for infant bone strength
A randomised, double-blind, controlled clinical trial on bone strength in term infants fed a high be…